Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:39 PM
Ignite Modification Date:
2025-12-26 @ 2:39 PM
NCT ID:
NCT00001806
Eligibility Criteria:
* INCLUSION CRITERIA:
At least one of the following:
Diagnosis of breast cancer, or DCIS prior to or at 45, or ovarian cancer prior to or at age 50;
Diagnosis of breast cancer with bilateral disease or multiple primaries or breast cancer and ovarian cancer in the same individual;
Diagnosis of breast or ovarian cancer and one first or second degree relative with breast cancer diagnosed prior to or at age 45, or ovarian cancer prior to or at age 50;
Diagnosis of breast or ovarian cancer and three relatives in the same lineage with breast or ovarian cancer; each affected individual must be a first- or second-degree relative to another of the affected individuals;
Diagnosis of breast or ovarian cancer and a first or second degree male relative with breast cancer;
A woman of Ashkenazi Jewish descent who meets any of the above criteria, with specified ages of onset of 50 for breast cancer and any age for ovarian cancer;
A male with breast cancer diagnosed at any age;
Documented BRCA mutation in the family.
All individuals must be able to give informed consent.
EXCLUSION CRITERIA:
Patients will be considered ineligible for any of the following reasons:
Any psychological disorder which may hinder the participant's ability to understand and process the material, based on a psychiatric consultation.
Inable to return for 2 visits.
Age under 18 years old.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT00001806
Study Brief:
Protocol Section:
NCT00001806